Valuation dashboard for UFP Technologies, Inc. (UFPT) with P/E 30.69, P/B 4.76, EV/EBITDA 20.1 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surg...
What would it be worth at its usual multiples?
Versus its usual multiples: fairly priced · Current P/E 30.7× · Multiples range: $252.70 · $284.50.
At the decade median (27.3×) $253 (-11 %); at its sector median (30.7×) $284 (0 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
Analysis Summary
UFP Technologies, Inc. reported revenue of $602.8M in the most recent fiscal year, growing at a 5-year CAGR of 27.4%. Net income reached $68.3M, with a 38.6% 5-year CAGR.
Trailing-twelve-month margins: gross margin 28.5%, operating margin 15.2%, net margin 11.4%.
At $284.50 (closing price, October 30, 2026), UFPT trades at a P/E of 30.69 and an ROE of 16.72%. Market capitalisation stands at $2.2B.
Balance sheet quality for UFPT: debt-to-equity ratio of 0.29, current ratio of 3.00 over the last 12 months. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 30.69 |
| Price / Book | 4.76 |
| EV / EBITDA | 20.1 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| UFPT | UFP Technologies, Inc. | $2.2B | 30.69 | 4.76 | 16.7% |
| GEHC | GE HealthCare Technologies Inc. | $34.6B | 19.99 | 2.98 | 16.1% |
| MDT | Medtronic Plc | $123.5B | 23.78 | 2.46 | 10.6% |
| ABT | Abbott Laboratories | $183.8B | 39.33 | 3.61 | 9.1% |
| 0Y6X.L | Medtronic Plc | $124.4B | 23.33 | 2.43 | 10.6% |
| SYK | Stryker Corporation | $111.9B | 31.08 | 4.76 | 15.6% |
| 0R2S.L | Stryker Corporation | $111.1B | 31.57 | 4.91 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.7B | 18.42 | 2.71 | 14.9% |
Price
| Price | $284.50 (closing price, October 30, 2026) |
| Market Cap | $2.2B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 16.72% |
| Return on Invested Capital | 12.65% |
| Return on Assets | 10.60% |
| Gross Margin | 28.50% |
| Operating Margin | 15.25% |
| Net Margin | 11.45% |
Related companies: GEHC · MDT · ABT · 0Y6X.L · SYK · 0R2S.L · 0HOY.L · BSX
Explore sector: Healthcare · Medical - Devices
More sections of UFPT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks